C07C 47/273
Containing halogen
Official title: containing halogen
C07C47/273 (Containing halogen) appears on 18 US grants and 9 published applications in this corpus.
Search patents in C07C- Granted patents
- 18
- Published applications
- 9
- Assignees
- 12
- Inventors
- 54
- Latest grant
- 24 Jul 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Process for producing alcohol analogue24 Jul 2018US 10,029,968 B2Takasago International Corporation
- Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use1 Nov 2016US 9,481,660 B2Erimos Pharmaceuticals LLC
- Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use8 Apr 2014US 8,691,845 B2Erimos Pharmaceuticals LLC
- Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use31 Jul 2012US 8,232,277 B2Erimos Pharmaceuticals LLC
- Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators8 Mar 2011US 7,902,224 B2Glaxo Group Limited
- Process for producing alcohol analogue19 Oct 2017US 2017/0297990 A1Takasago International Corporation
- Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaecutical use16 Feb 2017US 2017/0044121 A1Erimos Pharmaceuticals LLC
- Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaecutical use7 Aug 2014US 2014/0221384 A1Erimos Pharmaceuticals LLC
- Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use28 Feb 2013US 2013/0053378 A1Erimos Pharmaceuticals LLC
- Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use10 Dec 2009US 2009/0306070 A1Erimos Pharmaceuticals LLC
Most cited
By later US patents
- Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease22US 6,331,564 B1Ion Pharmaceuticals, Inc. · 2001
- Alkene, alkyne or cycloalkylene derivatives19US 4,873,329 AImperial Chemical Industries PLC · 1989
- 1-substituted tetralin derivatives, their preparation and their use16US 4,801,733 ABASF SE · 1989
- Alkene, alkyne or cycloalkylene derivatives15US 5,032,592 AImperial Chemical Industries PLC · 1991
- Novel substituted (4.2.0)bicyclooctane derivatives with valuable therapeutic properties9US 4,735,966 ASyntex (U.S.A.) Inc. · 1988